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Background: We describe the setup of a neonatal quality improvement tool and list which peer-reviewed
requirements it fulfils and which it does not. We report on the so-far observed effects, how the units can identify
quality improvement potential, and how they can measure the effect of changes made to improve quality.
Methods: Application of a prospective longitudinal national cohort data collection that uses algorithms to ensure
high data quality (i.e. checks for completeness, plausibility and reliability), and to perform data imaging (Plsek’s
p-charts and standardized mortality or morbidity ratio SMR charts). The collected data allows monitoring a study
collective of very low birth-weight infants born from 2009 to 2011 by applying a quality cycle following the steps
′guideline – perform - falsify – reform′.
Results: 2025 VLBW live-births from 2009 to 2011 representing 96.1% of all VLBW live-births in Switzerland display a
similar mortality rate but better morbidity rates when compared to other networks. Data quality in general is high
but subject to improvement in some units. Seven measurements display quality improvement potential in
individual units. The methods used fulfil several international recommendations.
Conclusions: The Quality Cycle of the Swiss Neonatal Network is a helpful instrument to monitor and gradually
help improve the quality of care in a region with high quality standards and low statistical discrimination capacity.
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In Switzerland, as in many other countries, participating in
a quality assessment collaborative has recently become
mandatory for all intensive care units. As a neonatology
unit’s patients cannot be compared with the average inten-
sive care patient, the Swiss Society of Neonatology decided
to design its own approach to quality assessment. In 2006 it
started with developing standards for the quality of care of
new-borns. The meanwhile implemented standards oblige
the Swiss neonatology units to fulfil requirements regarding
staffing, equipment and to apply evidence based protocols
in order to be classified into the internationally recognized
levels of neonatal care I – III [1]. At the third and top level,
units are required to participate in the Swiss Neonatal Net-
work. The Swiss Neonatal Network prospectively records* Correspondence: mark.adams@usz.ch
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reproduction in any medium, provided the orstandardized data for all children born alive between a ges-
tational age of 23 0/7 to 31 6/7 weeks or a birth weight
below 1501 g, all children as of 32 weeks gestational age
requiring continuous positive airway pressure (CPAP), all
children with perinatal encephalopathy requiring thera-
peutic hypothermia, and follow-up data of selected high-
risk collectives at two and five years corrected age. The col-
lected data is used for research on the one hand (see for
example [2,3]) and for quality assessment on the other. For
the latter, the network has devised a quality assessment tool
based on recent peer-reviewed findings and reviews that
comment on the proper use and efficacy of quality im-
provement initiatives in medicine.
In this publication we describe the setup of this tool and
list which requirements it fulfils and which it does not. We
report on the so-far observed effects and how the units can
monitor the effect of changes made in the clinic to improveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tions like a bed-side monitor where the clinic is the patient
under observation and the network’s tool is the monitor
that provides constant feed-back to the clinicians and alerts
them if and when their clinic’s data moves out of range. Fi-
nally, we propose that this setup approaches the yet to be
established requirement for evidence based medicine to
continuously test its own hypothesis.
Methods
Study collective
For the purpose of this study we limit our collective to all
live-born infants (including patients that died in the deliv-
ery room) born between 501 to 1500 g birth-weight as this
is the best described collective of preterm children and pro-
vides the most data for benchmarking comparisons. Data
was collected from 2006 to 2011 by all nine level III neo-
natal intensive care units either via exporting data from
their clinical information system (4 NICUs) and subsequent
import into the national database or via direct data entry
into the national database (5 NICUs). 98 items were col-
lected for all live-born children from birth until death or
first discharge home. 30 items were collected for all chil-
dren that died in the delivery room. All items are defined in
a manual [4]. They cover typical aspects of perinatal care,
demographics, common diagnoses and treatments, growth
and hospitalization duration.
Data collection and evaluation for this study were ap-
proved by the Swiss Federal Commission for Privacy
Protection in Medical Research. Participating units were
obliged to inform parents about the scientific use of the
anonymized data.
Data item selection
Out of the 98 items collected, a group of experts selected
those items that reflect the performance of the individual
units as opposed to items that cannot be modulated (such
as gender, birth defects, socio-economic status, etc.). The
selected items fulfil international standards for the descrip-
tion of mortality and common morbidities in very low
birth-weight children [5,6].
The selected items were then tested for their suitability
as quality indicators (QI’s) using the strict criteria of
QUALIFY [7]. QUALIFY was developed by the German
National Institute for Quality Measurement in Health
Care (BQS) as an instrument for the structural appraisal
of quality indicators in health care. It offers 3 criteria for
the proposed quality indicator’s relevance, 8 for its scien-
tific soundness, and 9 for its feasibility.
Data processing and imaging
Benchmarking diagrams (Figure 1): For the identification
of problematical areas, python-scripts (using matplotlib
[8]) extract and evaluate the network data over nightand display the results in one Plsek’s p-chart per item
per unit accompanied by a table with information on
collective size, effect size and number of missing entries
[9,10]. In our setting, Plsek’s p-chart displays the effect
size of an item over time with one dot per year for the
given unit versus the rest-collective. Horizontal lines re-
flect the mean rate over time, one for the unit and one
for the rest-collective, respectively, as well as one each
for the unit’s first, second and third standard deviation
of the mean value. Crossing the third standard deviation
of the mean in any given year is considered a significant
change.
Quality indicator diagrams (Figure 2) are generated after
the finalization of a year’s data collection using python-
scripts for the calculation and javascript/jquery for the pres-
entation of the data. The diagrams are based on the stan-
dardized mortality or morbidity ratio (SMR) model [11] in
which the entire collective is set as 1 and the unit’s value
per item is displayed in relation to the collective value with
a 95% confidence interval. Below the diagram, each value is
commented upon in a table listing information on unit rate,
SMR value, data completeness and reliability. There are
two sets of diagrams, one (Figure 2) displaying one item
per diagram with the nine units de-identified side by side in
a row, and one (not shown) displaying a selection of items
per unit so that the possible effect of one item upon an-
other can be observed. Outcome quality indicators (as op-
posed to process quality indicators) display both the
unadjusted and the risk-adjusted values next to each other.
Risk-adjustment is based on the units’ individual distribu-
tion of children into the gestational age groups below 24,
24–25, 26–27, 28–29, 30–31, and above 31 weeks.
Data quality
Upon entry into the national database, every record is
checked for data completeness and plausibility. Data
deemed as erroneous by the system are subject to be
corrected by the participating units.
The data collection is compared annually to the birth
registry of the Swiss Federal Statistical Office to ensure
record completeness.
Those items subject to the QUALIFY quality indicator
requirements are additionally checked for measurement
completeness, reliability and discrimination capacity:
Measurement completeness: Items to which the net-
work receives less than 90% answers from any given unit
are excluded from evaluation for the respective unit.
The degree of completeness is displayed in percentage
per unit below each diagram.
Reliability: Assuming that health care changes are gradual
as opposed to erratic, the quality indicator is analysed for
change over time. For this analysis, the QI in question is
scrutinized for the period of interest (2009–2011) and the
same time period in advance (2006–2008) for each unit
Figure 1 Benchmarking diagram. Plsek’s p-chart for mechanical ventilation for unit 8 versus the other level III NICUs in Switzerland (CH)
displaying historical annual percentages for 2000–2012. The mean (Avg) percentage over the entire period is 44.2% for the unit and 50.2% for CH.
The 1st and 2nd standard deviation (SD) of the unit are dotted lines (SD were calculated using the formula SD = SQRT {[mean percentage x
(1 - mean percentage)] / [sample size]}) whereas the 3rd SD are dashed lines. The unit’s upper and lower control limits (UCL = 58% and
LCL = 30.3%, respectively) are set by convention at ± 3 SD beyond the mean.
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into eight sections and the development of the QI is moni-
tored over time by plotting the QI’s rate and 95% confi-
dence interval side by side for each of the 8 sections. If the
confidence intervals of two neighbouring sections do not
overlap, an erratic change is assumed and the data of this
unit for this QI is deemed only partially reliable. If the inter-
vals do not overlap twice or more, the data from this unit is
deemed unreliable and is excluded from further evaluation.
If a section appears at a rate of 0% or 100% and the confi-
dence intervals therefore equal 0, no erratic change is as-
sumed and the next section is compared with the rate of
the previous section that was different from 0% or 100%.
The exact degree of reliability is displayed below each
diagram.
Discrimination capacity: statistical discrimination cap-
acity is optimized by the pooling of years and by moni-
toring data completeness. A difference between a
participating unit and the entire collective is considered
significant when the 95% confidence interval of the unit
does not overlap 1.
Quality cycle
Upon password protected login, the unit’s representative
can browse his/her unit’s data, error and missing lists and
evaluations. Twice per year, the representatives meet to dis-
cuss results.
This final step completes the quality cycle (Figure 3):
Swiss level III neonatology units apply evidence basedwritten protocols for medical and nursing staff and stand-
ard operating procedures for the collaboration with obste-
tricians and other paediatric subspecialties (Guideline) [1].
The guidelines are used in every day clinic (Perform) while
maintaining a Critical Incident Reporting System (CIRS).
Process and outcome are constantly monitored using the
above described data processing tools in order to locate
possible progress and setbacks (Falsify). At the biannual
meetings the results are discussed and change in individual
units or at the level of the network are initiated (Reform).
The meetings are setup such that two to three quality in-
dicators with noteworthy values (i.e., large differences be-
tween units, large difference between Swiss data and
published international data or large difference over time)
are chosen for the subsequent meeting and given to indi-
vidual unit directors for analysis. At the subsequent meet-
ing, the values for these quality indicators and their most
likely causes for difference according to Pareto [10] are
presented. The plenum then discusses changes that are
expected to lead to improvement. If a conclusion cannot be
reached due to lack of time, missing extra analysis or refer-
ences, the discussion can be continued in an online forum.
If a change is made, the effect of the change will be mea-
sured and scheduled for discussion at a subsequent meet-
ing. On-going data collection is planned in order to secure
long-term improvement.
Falsification: The concept of Falsification was devel-
oped by Sir Karl Popper, an important philosopher of
science of the 20th century. Popper is known for his
Figure 2 Quality indicator chart. Example QI-chart (Late onset sepsis) with a diagram above and a table below. The diagram is based on the
standardized mortality / morbidity ratio model and compares each unit (1–9) with the combination of all level III NICUs in Switzerland (CH). The
rate of the entire collective (CH) is set as 1 and is compared with the unit’s observed relative raw rate (diamond) or its risk-adjusted (currently
only gestational-age adjusted) observed vs. expected rate (square). A missing overlap of a 95% confidence interval marks a significant difference
between a unit and the entire community. The table below lists the detailed rate, SMR, data completeness, reliability and whether the difference
is significant (as this is not always clearly visible in the diagram). The rate of the entire collective (CH) is in the top left corner of the diagram.
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ductivist form of scientific method in favour of empirical
falsification. According to Popper, a theory should be
considered scientific if, and only if, it is falsifiable. He
considers science to be “a critical activity. We test our
hypotheses critically. We criticize them to find mistakes;
and in hope to eliminate the mistakes and so come
closer to the truth” [12].Statistical analysis
For this publication, two-sided Mann–Whitney U-
tests were performed to compare mean values of two
independent variables. To determine differences in
the distribution of a variable, the Pearson’s Chi-
square test was used. Probability levels below 0.05
were considered significant. Statistical analyses were
carried out with Python release 2.7 using matplotlib
and Microsoft Excel 2011.Results
The 9 Level III neonatology units of the Swiss Neonatal
Network registered 2025 live-births with a birth weight
between 501 to 1500 g from 2009 to 2011 (Table 1).
They represent 96.1% of all very low birth-weight live-
births in Switzerland according to the birth registry of
the Swiss Federal Statistical Office [13] (96.2% for 2009,
96.3% for 2010 and 96.0% for 2011). The number of chil-
dren per unit range from 95 to 388 for the pooled 3 year
period. A comparison to the rates of the Vermont
Oxford Network [14] shows that the population is not
significantly different as far as gender distribution and
rate of children ′small for gestational age′ is concerned.
The rate of multiple births however is significantly
higher in Switzerland. Concerning the outcome, the
mortality is not significantly different, whereas several
important morbidities (PDA, NEC, late onset sepsis,
oxygen at 36 weeks gestational age, ROP stage 3–4, and
PIH stage 3–4) are lower in Switzerland.
Figure 3 Quality cycle. Quality cycle of the Swiss
Neonatal Network.
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which the lowest (min.) and highest (max.) value are
shown in Table 1, are surprisingly large and in many
cases result in a confirmed significance (* in Table 1).
From the 24 variables used for the evaluation of unit
to unit differences (Table 2), 23 are available as
benchmarking diagrams (Figure 1) and 20 as quality in-
dicator diagrams (Figure 2), thereof 5 for process and 15
for outcome indicators.
Data completeness in general is high. In some areas
there is an improvement potential, for instance in the
variables of prenatal steroids, oxygen at 36 weeks gesta-
tional age, growth, and length of stay. The low data
completeness for ROP 3–4 reflects the fact that many
units in Switzerland have ceased to screen children for
ROP above 31 weeks gestational age.
Reliability should be tested for those units whose data
was calculated as being unreliable: 1 unit for caesarean
section, 1 for full prenatal steroids, 1 for CPAP w/o
mech. vent., and 1 for surfactant. The reliability testing
system of the network is somewhat prone to produce
false negative results because of the small size of some
of the participating units. If high data reliability can be
verified by review of the original case documentation,
the testing system can be manually overridden.
Of the twenty criteria required for quality indicators
according to QUALIFY [7], the network applies fourteen
as instructed and three in a modified version (Table 3).
The remaining three criteria are omitted as incompatible.
The Quality cycle of the network also fulfils all re-
quirements made by the Swiss Academy of Medical Sci-
ences [16] with the exception that it does not meet thestandard of having the data independently externally
audited.
In order to identify possible areas of quality improve-
ment, the network members apply a pre-defined proced-
ure: Using benchmarking diagrams, units can identify
problematical areas by observing the development of
their raw data over time. Using quality indicator dia-
grams, a suspected problem can be verified under more
controlled conditions for a given time period. The thus
identified problem is presented and discussed at the bi-
annual meeting of the units’ directors and strategies for
improvement are sought. After implementation at the
clinic, the Plsek’s p-charts finally allow the unit to ob-
serve the effect of a change made in the clinic with up
to date values of the unit.
So far, the network’s data processing and quality cycle
has allowed the revision of the Swiss Neonatal Society‘s
guidelines for perinatal care at the limit of viability in
2011 [17] where the recommended gestational age for
engaging into intensive care was lowered from 25 to
24 weeks [18]. It has also lead to the replacement of
hand disinfectant in one of the participating units and to
the revision of oxygen saturation levels in all Swiss Level
III units.
Discussion
Identification of improvement areas
In the field of neonatology there are no available gold
standards in the sense of “best available test or bench-
mark under reasonable conditions”. It is therefore diffi-
cult to define good quality. Instead, one has to rely on
the comparison between units which is prone to bias be-
cause not all units work under the same conditions.
Some have a higher risk for mortality or morbidities
than others because of the nature of the collective they
treat. We therefore believe that a comparison should not
classify a unit with such crude a label as performing with
good or bad quality. Instead, we propose a concept
where units performing worse in areas where others
excel can profit from the latter and improve their quality
without losing face. It helps that the detection tool is
sensitive enough to show that every unit has areas to im-
prove and that Switzerland is small enough for all partic-
ipants to know each other well. We have thus adopted
two important aspects of the Vermont Oxford Network’s
innovative NICQ system where a small number of units
respectfully help each other by objectively communicat-
ing their results and holding themselves accountable
[11].
Areas where at least one Swiss unit differs significantly
from the combined Swiss total and which thus display
improvement potential lay in the rates of caesarean sec-
tion, prenatal steroids, mortality, early onset sepsis, late
onset sepsis, growth and measured UapH. Berger et al.
Table 1 Data analysis
Swiss neonatal network Vermont-oxford-network EuroNeoNet Difference VON-SNN
All units min. max.
Years 2009-2011 2009 2011 2010 2010 -
Units 9 - - ca. 850 96 -
N 2025 95 388 53862 6389 -
Sex male 52.2% 42.3% 59.8% 51.0% 50.4% 0.29
Multiples 36.0% 24.9% 44.2% 28.0% 33.1% <0.001
Small for Gestation 19.2% 15.4% 21.4% 21.0% 0.05
Inborn 95.0% 91.5% 97.8% 86.0% <0.001
UapH measured 82.7% *64.4% *94.7%
Caesarean Section 77.2% *63.4% *88.5% 73.0% 72.3% <0.001
Full prenatal steroids 71.1% *59.8% *79.8%
Any prenatal steroids 87.9% 79.7% *98.6% 78.0% 83.5% <0.001
Major birth defects 5.0% 3.4% 7.0% 5.0% 1
Mortality 13.6% 5.8% *19.4% 12.6% 10.8% 0.185
PDA† 28.3% *11.2% *41.8% 37.0% <0.001
PPH† 5.4% *0.9% *12.4%
NEC† 2.0% 0.6% 3.6% 6.0% 5.9% <0.001
Early Onset Sepsis† 2.0% 0.6% *7.4% 2.0% 3.5% 1
Late Onset Sepsis† 7.4% 2.5% *11.7% 15.0% 25.5% <0.001
O2 at 36w GA‡ 9.5% 3.0% 19.8% 30.0% 10.7% <0.001
Mechanical ventilation† 51.8% *40.6% *71.5% 64.0% <0.001
CPAP† 78.4% *67.3% *86.3% 69.0% <0.001
CPAP w/o mech. vent.† 31.3% *12.6% *47.6%
Surfactant† 45.9% *25.1% *65.2% 64.0% 51.8% <0.001
ROP stage 3-4† 2.3% 0.0% 5.3% 6.0% 2.7% <0.001
PIH stage 3-4† 6.4% 3.8% 9.8% 9.0% 7.7% <0.001
cPVL† 2.3% 0.0% 4.7% 3.2% 3.9% 0.027
Growth† 9.4% *7.7% *14.5%
Surgery† 10.3% 5.0% 15.2% 16.0% <0.001
Length of stay† 56.9 46.9 65.2
Length of stay‡ 55.0 44.2 64.4 64.8 n/a
Data analysis and comparison to Vermont-Oxford-Network [14] and EuroNeoNet [15] for all live-births between 501-1500 g birth-weight (without delivery room
deaths (†), or that have survived until discharge home (‡)). For a definition of the listed items see [2,4]. The first column shows the mean Swiss value. The second
and third columns render the lowest (min.) and highest (max.) value achieved by one of the network units. An asterisk (*) marks where each value significantly
differs from the value of the entire Swiss collective. UapH: umbilical artery pH, PDA: patent ductus arteriosus, PPH: positive pulmonary hypertension, NEC:
necrotizing enterocolitis, CPAP: continuous positive airway pressure, ROP: retinopathy of prematurity, PIH: periventricular- intraventricular haemorrhage,
cPVL: cystic periventricular leucomalacia, growth: rate of children born small for gestational age that have surpassed the 10th weight percentile by discharge.
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line population demographics or differences in the inter-
pretation of national recommendations (for children
born at the limit of viability) influence survival rates of
extremely preterm infants in the individual units which
also suggests the presence of areas for improvement
[18].
Differences between PDA, PPHN, mechanical ventila-
tion, CPAP, CPAP without mechanical ventilation, and
surfactant usage on the other hand are suspected to bereflections of clinical treatment strategy, different diag-
nostics or geographical location and are therefore of
limited use for quality assessment. Yet they can be
important when investigating the most likely cause of a
quality problem in another measurement.
Quality of data set
The variables used for the benchmarking and quality
indicator calculations were chosen because of their cap-
acity to describe clinically important and/or modifiable
Table 2 Data quality
Bench-marking Quality indicators Data completeness Reliability
All units min. max.
Inborn yes yes (P) 99.6% 96.3% 100.0% 8 / 1 / 0
UapH measured no yes (P) 100.0% 100.0% 100.0% 6 / 3 / 0
Caesarean Section yes yes (P) 100.0% 100.0% 100.0% 4 / 4 / 1
Full prenatal steroids yes yes (P) 96.3% 90.8% 99.7% 5 / 3 / 1
Any prenatal steroids yes yes (P) 96.3% 90.8% 99.7% 6 / 3 / 0
Major birth defects yes no 100.0% 100.0% 100.0% -
Mortality yes yes (O) 100.0% 100.0% 100.0% 6 / 3 / 0
PDA yes yes (O) 100.0% 100.0% 100.0% 6 / 3 / 0
PPH yes yes (O) 100.0% 100.0% 100.0% 7 / 2 / 0
NEC yes yes (O) 100.0% 100.0% 100.0% 8 / 1 / 0
Early Onset Sepsis yes yes (O) 100.0% 100.0% 100.0% 8 / 1 / 0
Late Onset Sepsis yes yes (O) 100.0% 100.0% 100.0% 6 / 3/ 0
O2 at 36w GA yes yes (O) 97.8% 91.6% 100.0% 6 / 3 / 0
Mechanical ventilation yes yes (O) 100.0% 100.0% 100.0% 6 / 3 / 0
CPAP yes yes (O) 100.0% 100.0% 100.0% 4 / 4 / 0
CPAP w/o mech. vent. yes yes (O) 100.0% 100.0% 100.0% 6 / 2 / 1
Surfactant yes yes (O) 100.0% 100.0% 100.0% 7 / 1 / 1
ROP stage 3-4 yes yes (O) 83.2% 72.4% 95.8% 9 / 0 / 0
PIH stage 3-4 yes yes (O) 98.9% 97.7% 100.0% 8 / 1 / 0
cPVL yes yes (O) 98.9% 97.7% 100.0% 9 / 0 / 0
Growth yes yes (O) 97.9% 92.7% 100.0% 6 / 3 / 0
Surgery yes no 100.0% 100.0% 100.0% -
Length of stay yes no 98.7% 90.5% 100.0% -
Length of stay yes no 98.6% 90.0% 100.0% -
Variables chosen for benchmarking (yes/no) and quality indicator evaluation (yes/no) with their completeness and reliability. (P): process quality indicator (O):
outcome quality indicator. Data completeness is given as mean value for all units and with the value of the unit representing the minimum and the maximum
completeness. Data is categorized according to the number of units with reliable / partially reliable / unreliable data.
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in the Baby-MONITOR, a composite indicator for qual-
ity recently published by Profit et al. (2011) that both an
expert panel as well as practicing clinicians agreed upon
as having high face validity [19,20]: prenatal steroids, late
onset sepsis, oxygen at 36 weeks postmenstrual age,
growth velocity and in-hospital mortality. However, in
order to complete Profit et al.’s choice of measures in-
cluded into the Baby-MONITOR, the network would
need to add timely ROP exam, pneumothorax, human
milk feeding at discharge and hypothermia on admis-
sion. Incidentally, all except the latter are routinely col-
lected by the network and will therefore be included in
the near future.
Of the 20 criteria required for quality indicators
according to QUALIFY [7], the network applies 14 as
instructed and 3 in a modified version: Reliability would
best be tested using a test-retest or an inter-rater pro-
cedure. This is however not possible because of thelimited funding available. Instead, we established an al-
gorithm designed to flag data that are selected for a par-
tial test-retest procedure. The other modifications were
necessary because of the relatively small collective size
in Switzerland where some of the units only have ca. 30
cases per year: The ability for statistical discrimination
in QUALIFY requires limits as of which an outcome
switches from good to poor quality in order to calculate
the minimal amount of patients required by a participat-
ing unit to guarantee a secure statistical statement. Such
limits are not yet available in neonatology. Since the low
collective size in Switzerland cannot be modified and the
network does not have the intention to define good or
bad quality, but rather to identify possible areas of im-
provement, we instead optimize statistical reliability by
pooling years and optimize finding relevant results by of-
fering the same data for consecutive pooled years in
three different collectives (very preterm, very low birth
weight and extremely preterm). This way, large and
Table 3 List of QUALIFY criteria
QUALIFY criteria SNN
Relevance Importance of the quality characteristic
captured with the quality indicator for
patients and the health care system
applied
Benefit applied
Consideration of potential risks / side effects applied
Scientific
soundness
Indicator evidence applied
Clarity of the definitions (of the indicator
and its application)
applied
Reliability modified
Ability of statistical differentiation modified
Risk adjustment modified
Sensitivity -
Specificity -
Validity applied
Feasibility Understandability and interpretability for
patients and the interested public
-
Understandability for physicians and nurses applied
Indicator expression can be influenced
by providers
applied
Data availability applied
Data collection effort applied
Barriers for implementation considered applied
Correctness of data can be verified applied
Completeness of data can be verified applied
Complete count of data sets can be verified applied
List of the QUALIFY criteria developed by the German National Institute for
Quality Measurement in Health Care (BQS). SNN: Swiss Neonatal Network.
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even if they have not yet reached statistical significance.
Finally, risk-adjustment has been simplified to reflect
only the units’ individual distribution into gestational
age groups. Any additional risk-adjustment would strat-
ify the small collectives into even smaller groups making
no more statistical sense.
The network omits 3 of the QUALIFY criteria: Sensi-
tivity and Specificity calculation require the presence of
gold-standards which have not yet been established for
the variables observed in this study. Comprehensibility
and interpretability for patients and the interested public
have been omitted as we believe the network’s quality
cycle to require too much expertise to be distributed to
the general public.
Serviceability for quality improvement
Ellsbury et al. (2010) [10] maintain that despite the com-
plexity of the NICU environment, significant improve-
ments can be accomplished by use of basic QI
methodology. The network can provide several aspects
of the required methodology postulated by Ellsbury et al.The tools to identify a clinically important and modifi-
able outcome, the setting for establishing a goal for im-
provement and the structure for securing a long-time
establishment of the change by continuous data collec-
tion and review. Hulscher et al. (2013) particularly point
out the requirement of latter as they observed that if
teams remained intact and continued to gather data,
chances of long-term success were higher [21].
The remaining aspects of the methodology required
according to Ellsbury et al. (2010) however need to be
provided by the units directly: a team that finds the “vital
few” causes for the problem according to the Pareto
principle (as opposed to the “trivial many” causes) and
that is motivated to implementing the change, preferably
a system change as opposed to tinkering [10].
Starting from a different vantage point, Lloyd (2010)
describes milestones required for reaching quality im-
provement [22]. The network observes these milestones:
The aim of the network’s quality cycle is clearly speci-
fied, it follows a concrete concept, the items and how
they are measured are well defined, a well-developed
data collection plan exists and the data are analysed both
statically and analytically. We however prefer Plsek’s p-
charts over the run or Shwehart charts proposed by
Lloyd due to the latter’s complexity which makes them
difficult to program for them to be produced automatic-
ally, and because of the limited population size in some
of the participating units which would limit the explana-
tory power of the run or Shwehart charts. Noteworthy
however is that Lloyd’s sequence for improvement paral-
lels our proposed quality cycle (Figure 3) if rotated anti-
clockwise by 90 degrees. His “act-plan-do-study” trans-
lates into our “guideline (plan)-perform (do)-falsify
(study)-reform (act)” which again is listed in Ellsbury
et al. (2010) congruently as “plan-do-study-act” and is
said to be a simple feedback cycle with a long history of
successful use in improvement activities in industry and
many other fields [10,11].
Falsification
Kelle et al. (2010) maintain that constant doubt is a basic
tenor in evidence based medicine and conclude that this
doubt can be used to detect typical misperceptions and
erroneous conclusion [23]. Swiss Level III neonatology
units apply evidence based guidelines and in centre or
multicentre based studies also develop such guidelines
using random controlled trials [24]. Under the premises
that neither scientific research nor clinical performance
are immune to human error, in particular when working
with fully established and proven evidence based guide-
lines, we propose that a long-term constant monitoring
of key clinical measurements will help in the establish-
ment of useful guidelines versus ineffective ones because
it allows observing the effect of the guidelines on the
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point. In other words, we believe constant doubt is a
prerequisite for evidence based medicine and therefore
its application should be continuously tested (respect-
ively falsified) in order to secure that the knowledge
gained by statistical interpretation of probabilities really
is a reflection of the true nature of the problem for
which the evidence based solution was found. The net-
work’s tool however cannot be seen as a final answer to
this dilemma, merely as a step in the direction of
accepting the constant doubt.
This is another reason why we maintain that the net-
work’s goal is not to classify good or bad quality but is
instead designed to detect possible errors by performing
constant falsification. Obviously this is open for im-
provement by augmenting the range of observed mea-
surements and further refining its methodology.
Limitations
Statistical discrimination requires large numbers or large
differences. Swiss neonatology units offer neither: The
units have approximately 30 to 160 cases per year and
comparable quality standards. That is why we need to
pool years and deviate somewhat from the recommenda-
tions made by QUALIFY.
The choice of items measured by the network is so far
dependent on routinely collected variables for research.
New items can be added but the network has limited it-
self to performing changes in the data collection only
every five years in order not to risk the quality of the
data collection of the existing items. Data pooling and
the necessity to gather twice the amount of data to per-
form our reliability exam, result in a productive routine
integration of a new item only after 4 years. The waiting
however can be shortened, if need be, by replacing the
reliability test through a test-retest method. Also, pre-
liminary data can be observed on a unit’s level from the
beginning of data collection with limited explanatory
power. Nevertheless, due to its complexity, the network’s
tool is not very flexible.
As the risk-adjustment for each unit is different, the
units’ values cannot be directly compared to each other
in the QI chart. We however deem this as irrelevant, as
we are interested in each unit’s performance vs. the col-
lective and not in the direct competition between units.
The Swiss Neonatal Quality Cycle is still in its begin-
ning phase. The effects listed at the end of the results
section result from preliminary meetings held during the
development of the quality cycle. We are currently mon-
itoring the measures undertaken to improve quality in
order to be able to concretely report on observable ef-
fects over time. But even if we can report on a signifi-
cant change attributed to the quality cycle, we will not
be able to empirically prove that the observed change isin fact caused by the quality cycle, as for instance
recommended by Schouten et al. (2008 and 2013)
[21,25]. In essence, we can never rule out that other sim-
ultaneous changes (such as new medication or evidence
based measures) are in fact responsible. The setup does
not fulfil the criteria met by controlled trials and has no
intention to do so.
Conclusions
The Quality Cycle of the Swiss Neonatal Network is a
helpful instrument to monitor and gradually help im-
prove the quality of care in a region with high quality
standards and low statistical discrimination capacity.
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